Amazon Scorpion Venom Shows Promise Against Breast Cancer
Scorpion venom compound from the Amazon shows strong anticancer effects, with potential as a new breast cancer treatment.
Summary:
Brazilian scientists have identified a compound in Amazonian scorpion venom that kills breast cancer cells in lab tests. Known as BamazScplp1, the peptide matches chemotherapy-level efficacy with the potential for fewer side effects.
Key Takeaways:
- Breakthrough compound: BamazScplp1 induces necrotic cell death in breast cancer cells, rivaling paclitaxel.
- Lab-grown scalability: Scientists are reproducing the peptide via yeast-based expression systems.
- Global research momentum: Adds to growing evidence of scorpion venom’s anticancer properties across subtypes.
Why It Matters:
Breast cancer remains a leading cause of death among women, and chemotherapy side effects often limit treatment options. Natural compounds like BamazScplp1 could pave the way for gentler, more targeted therapies—especially for drug-resistant cancers.
Source Link:
Amazon scorpion toxin kills breast cancer cells
The venom of a common species of Amazonian scorpion may give rise to a potential drug for treating a cancer that is one of the leading causes of death in women.
FAPESP
A common Amazonian scorpion, Brotheas amazonicus, is the source of a newly discovered compound that may help fight breast cancer with fewer side effects.
